Drug auditing method and device based on mutual exclusion recognition, computer system and readable storage medium
A drug and data technology, applied in the field of drug review method based on mutually exclusive identification, computer system and readable storage medium, and device, can solve the problems of high probability of omission, affecting the accuracy of review results, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0068] see figure 1 , this embodiment provides a drug review method based on mutually exclusive identification, such as figure 1 shown, including the following steps:
[0069] S1: collect record data, and preprocess the record data to obtain sample data;
[0070] In the above embodiment, the collection of record data is to obtain the prescription records of each patient in a specific disease (such as diabetes) through the platform, and each record data includes patient information, drug list information corresponding to the patient information, and each The drug data in a drug list. It should be noted that the drug lists mentioned in this embodiment are drug data collections issued by professionals for different patients. The drug data are drug names, and the drug names are all professional names. It can be obtained directly from the platform, such as: dexamethasone, rosiglitazone, etc. Each drug data corresponds to a drug, and the subsequent drugs are consistent with the dr...
Embodiment 2
[0135] see Figure 8 , a drug review device 7 based on mutually exclusive identification in this embodiment, including
[0136] A preprocessing module 71, configured to collect record data, and perform preprocessing on the record data to obtain sample data, wherein the sample data includes at least one drug list information, and each drug list information includes at least one drug data;
[0137] The first processing module 72 is used to calculate the similarity of each of the drug data, and obtain the drug data whose similarity meets the preset first condition to generate the first processing data;
[0138] The second processing module 73 is used to calculate the correlation degree of each of the drug data and obtain the second processing data;
[0139] The synthesis module 74, based on the first processed data and the second processed data, generates mutually exclusive drug data sets corresponding to each of the drug data as target data;
[0140] In the above embodiment, e...
Embodiment 3
[0150] To achieve the above object, the present invention also provides a computer system, such as Figure 10 As shown, the computer system includes at least one computer device 8, and the components of a drug review device 7 based on mutual exclusive identification in Embodiment 2 can be dispersed in different computer devices, and the computer device can be a smart phone executing a program, Tablet PCs, laptops, desktop computers, rack servers, blade servers, tower servers or cabinet servers (including independent servers, or server clusters composed of multiple servers), etc. The computer equipment in this embodiment at least includes but is not limited to: a memory 81 and a processor 82 that can communicate with each other through a system bus, such as Figure 10 shown. It should be pointed out that, Figure 10 Only a computer device with components is shown, but it should be understood that implementing all of the illustrated components is not a requirement and that mor...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More